TREA

Ultrasonic authentication for dialysis

Follow

Information

  • Patent Grant
  • 11504458
  • Patent Number
    11,504,458
  • Date Filed
    Monday, October 7, 2019
    4 years ago
  • Date Issued
    Tuesday, November 22, 2022
    a year ago
Information
Abstract
A system for blood treatment can include a dialysis machine and an ultrasonic authentication device connected to the blood treatment machine, the ultrasonic authentication device configured to scan a label and send signals containing label information to the dialysis machine.
Description
TECHNICAL FIELD

This disclosure relates to ultrasonic authentication for dialysis.


BACKGROUND

Dialysis is a treatment used to support a patient with insufficient renal function. The two principal dialysis methods are hemodialysis and peritoneal dialysis.


During hemodialysis (“HD”), the patient's blood is passed through a dialyzer of a dialysis machine while also passing a dialysis solution or dialysate through the dialyzer. A semi-permeable membrane in the dialyzer separates the blood from the dialysate within the dialyzer and allows diffusion and osmosis exchanges to take place between the dialysate and the blood stream. These exchanges across the membrane result in the removal of waste products, including solutes like urea and creatinine, from the blood. These exchanges also regulate the levels of other substances, such as sodium and water, in the blood. In this way, the dialysis machine acts as an artificial kidney for cleansing the blood. Generally, HD treatments require disposable items (e.g., tubing sets, fluids, dialyzers, etc) to be connected to the HD machine.


SUMMARY

In one aspect of the invention, a system for blood treatment includes a dialysis machine, and an ultrasonic authentication device connected to the dialysis machine. The ultrasonic authentication device is configured to scan a label using ultrasonic signals and to send identified label information to the dialysis machine.


In another aspect of the invention, a method of operating a dialysis system includes scanning a label with an ultrasonic authentication device connected to a dialysis machine, comparing the label information against stored information to determine whether the label corresponds to a required consumable for the dialysis machine, and instructing the user to proceed or halt setup based on the compared information. The ultrasonic authentication device is configured to scan the label using ultrasonic signals and to send identified label information to the dialysis machine.


Implementations can include one or more of the following features.


In some implementations, the label information includes a lot number, a material description, a sku, an expiration date, a size, and/or a concentration.


In certain implementations, the label information is positioned on a clear label.


In some implementations, the system further includes a consumable having a label configured to be scanned by the ultrasonic authentication device.


In certain implementations, the consumable is a saline bag, a dialyzer, a tubing set, and/or a drug.


In some implementations, the label is positioned on a consumable being installed on the dialysis machine.


Embodiments can include one or more of the following advantages.


The ultrasonic authentication devices described herein can help to ensure that a correct disposable (e.g., solution, drug, fluid line set) is connected to the hemodialysis device. This reduces patient risk caused by user error, expired materials, or incompatible disposables. In addition, the ultrasonic authentication devices described herein are also compatible with various labeling applications (e.g., clear labels, paper labels, and/or solid foil/metal labels.) This versatility helps to provide a user-friendly experience when authenticating labels and helps to reduce the risk of errors by the authentication device.


The details of one or more implementations are set forth in the accompanying drawings and the description below. Other aspects, features, and advantages will be apparent from the description and drawings, and from the claims.





DESCRIPTION OF DRAWINGS


FIG. 1 shows a blood treatment system including a blood treatment machine and an ultrasonic authentication device where the blood treatment machine is configured to identify label information.



FIG. 2 shows the ultrasonic authentication device of FIG. 1.



FIG. 3 shows a method of using an ultrasonic identification device in preparation for a dialysis treatment.





DETAILED DESCRIPTION

In certain aspects, an ultrasonic authentication device can be used to identify information from labels on items used in a dialysis treatment. These items can removeable or connectable to a blood treatment device (e.g., disposables, accessories, fluids, and/or drugs.)



FIG. 1 shows a blood treatment system 100 that includes a blood treatment machine (e.g., hemodialysis machine 102) and an ultrasonic authentication device 104, connected to hemodialysis machine 102. The ultrasonic authentication device 104 includes an ultrasonic signal transmitter 106 configured to send ultrasonic signals. An ultrasonic signal receiver 108 is configured to receive reflected ultrasonic signals.


In FIG. 1, the hemodialysis machine 102 and ultrasonic authentication device 104 are connected electronically. A user interface 132 is mounted on or integrated in the hemodialysis machine 102 and is operably controlled by a controller (e.g., a controller 202 shown in FIG. 2) of the hemodialysis machine 102. The user interface 132 can be configured to display information related to the labeling information received by the ultrasonic signal receiver 108. This labeling information can include information related to the function or source of the item (e.g., lot number, description, sku, expiration date, size, and/or concentration.)


In operation, a blood pump 122 of the hemodialysis machine 102 pumps blood through an extracorporeal circuit 117 connected to the hemodialysis machine 102. More specifically, the blood pump 122 draws blood out of a patient 101 via an arterial patient line 118 and forces the blood through a blood chamber of a dialyzer 112. As the blood passes through the blood chamber of dialyzer 112, dialysate passes through a dialysate chamber of the dialyzer 112, so that the blood is cleared of toxins. The cleansed blood then flows through a venous air trap 120 where any air in the blood is collected and is returned to the patient via a venous patient line 110. A saline bag 107 is connected to the venous air trap 120 for introducing saline into the cleansed blood.


In some cases, before identifying the label information, the controller 202 of hemodialysis machine 102 will generate a notification to notify the operator that label information is required. The notification may be visual, auditory, and/or vibrational.


After the ultrasonic authentication is completed, label information is transmitted from the ultrasonic authentication device 104 to hemodialysis machine 102 via the ultrasonic signal transmitter 106 and the ultrasonic signal receiver 108. The ultrasonic signal receiver 108 receives the label information and user interface 132 then optionally displays the label information, an error, and/or further instructions to the user.



FIG. 2 is a schematic illustration of the ultrasonic authentication device 104 including the ultrasonic signal transmitter 106 and the ultrasonic signal receiver 108. The saline bag 107 is an exemplary disposable and includes a label 109. The label 109 can be formed from different labeling applications (e.g., clear labels, paper labels, and/or solid foil/metal labels.) In this example, a user places the bag before the ultrasonic authentication device 104 before use. The ultrasonic authentication device 104 transmits high-frequency sound waves 204 directed at the label 109 and receives reflected waves 206. Based on the reflected waves 206 the controller 202 identifies labeling information from the label 109. In some cases, the received labeling information is displayed to the user on the user interface 132. In other cases, the received labeling information is first compared against expected information. If the information matches expected or acceptable parameters, the treatment or set up is allowed to progress. If the information does not match, the user can be shown an error (e.g., a request to rescan, the reason for rejection, and/or a request to scan a new saline bag.)



FIG. 3 is a flow chart illustrating a method 300 using an ultrasonic identification device in preparation for a dialysis treatment. To prepare for treatment, the hemodialysis machine 102 notifies 304 the user (e.g., via the user interface 132) that authentication is required before connecting a saline bag. Then, the label of the saline bag is scanned 306 by the ultrasonic authentication device when the user places the label near the ultrasonic authentication device. A controller of the HD machine then compares 308 the received label information with expected information. If the label information matches the expected information, the user is instructed to proceed 310 with machine set up. If the information does not match, the user is shown an error (e.g., a request to rescan, the reason for rejection, and/or a request to scan a new saline bag). While FIG. 3 illustrates a method for verifying label information of a saline bag, other connectable components of a dialysis system could be similarly verified.


Alternative Implementations


The examples described herein can be implemented in a variety of ways without departing from the scope of the specification.


While the authentication device 104 is generally shown as part of the hemodialysis machine 102, in some cases, the authentication device could be detachable or connectable to a medical device.


While the saline bag 107 and the label 109 are generally described, labels for other removable components could also be used. For example, a label on the extracorporeal circuit or the dialyzer could be authenticated using the authentication device 104.


Elements of different implementations described herein may be combined to form other implementations not specifically set forth above. Elements may be left out of the structures described herein without adversely affecting their operation. Furthermore, various separate elements may be combined into one or more individual elements to perform the functions described herein.


Various embodiments discussed herein may be combined with each other in appropriate combinations in connection with the system described herein. Additionally, in some instances, the order of steps in a method may be modified, where appropriate. Further, various aspects of the systems described herein may be implemented using software, hardware, a combination of software and hardware and/or other computer-implemented modules or devices having the described features and performing the described functions.


Software implementations of aspects of the system described herein may include executable code that is stored in a computer-readable medium and executed by one or more processors. The computer-readable medium may include volatile memory and/or non-volatile memory, and may include, for example, a computer hard drive, ROM, RAM, flash memory, portable computer storage media such as a CD-ROM, a DVD-ROM, a flash drive and/or other drive with, for example, a universal serial bus (USB) interface, and/or any other appropriate tangible or non-transitory computer-readable medium or computer memory on which executable code may be stored and executed by a processor. The system described herein may be used in connection with any appropriate operating system.


Several implementations have been described. Nevertheless, it will be understood that various modifications may be made without departing from the spirit and scope of the description. Accordingly, other implementations are within the scope of the following claims.

Claims
  • 1. A system for blood treatment, the system comprising a dialysis machine; andan ultrasonic authentication device connected to the dialysis machine, the ultrasonic authentication device configured to scan a label using ultrasonic signals and to send identified label information to the dialysis machine.
  • 2. The system of claim 1, further comprising a controller configured to generate a user notification of required label authentication before a treatment begins.
  • 3. The system of claim 1, wherein the label information comprises a lot number, a material description, a sku, an expiration date, a size, and/or a concentration.
  • 4. The system of claim 1, wherein the label information is positioned on a clear label.
  • 5. The system of claim 1, further comprising a consumable having a label configured to be scanned by the ultrasonic authentication device.
  • 6. The system of claim 5, wherein the consumable is a saline bag, a dialyzer, a tubing set, and/or a drug.
  • 7. A method of operating a dialysis system, the method comprising: scanning a label with an ultrasonic authentication device connected to a dialysis machine, the ultrasonic authentication device being configured to scan the label using ultrasonic signals and to send identified label information to the dialysis machine;comparing the label information against stored information to determine whether the label corresponds to a required consumable for the dialysis machine; andinstructing the user to proceed or halt setup based on the compared information.
  • 8. The method of claim 7, wherein the label is positioned on a consumable being installed on the dialysis machine.
  • 9. The method of claim 7, wherein the label is a clear label.
  • 10. The method of claim 7, wherein the label information comprises a lot number, a material description, a sku, an expiration date, a size, and/or a concentration.
  • 11. The method of claim 7, wherein the consumable is a saline bag, a dialyzer, a tubing set, and/or a drug.
CLAIM OF PRIORITY

This application claims priority under 35 USC § 119(e) to U.S. Patent Application Ser. No. 62/746,720, filed on Oct. 17, 2018, the entire contents of which are hereby incorporated by reference.

US Referenced Citations (280)
Number Name Date Kind
1406372 Grapp Feb 1922 A
1689432 Hartwig Oct 1928 A
2107173 Bauer Feb 1938 A
2982895 Exon May 1961 A
3130289 Katzman et al. Apr 1964 A
3605783 Pecker et al. Sep 1971 A
3694625 Cole Sep 1972 A
3738356 Workman Jun 1973 A
3762557 Tudor et al. Oct 1973 A
3808401 Wright et al. Apr 1974 A
3987385 Diller et al. Oct 1976 A
4014319 Favre Mar 1977 A
4136708 Cosentino et al. Jan 1979 A
4315523 Mahawili et al. Feb 1982 A
4489535 Veltman Dec 1984 A
4503706 Kolodjski Mar 1985 A
4508622 Polaschegg et al. Apr 1985 A
4613325 Abrams Sep 1986 A
4618343 Palsulich Oct 1986 A
4676467 Palsulich Jun 1987 A
4718447 Marshall Jan 1988 A
4734198 Harm et al. Mar 1988 A
4753370 Rudick Jun 1988 A
4756330 Tischer Jul 1988 A
4756331 Stegmaier Jul 1988 A
4778451 Kamen Oct 1988 A
4808161 Kamen Feb 1989 A
4812239 Mills Mar 1989 A
4826482 Kamen May 1989 A
4869286 Williams et al. Sep 1989 A
4895657 Polaschegg Jan 1990 A
4902282 Bellotti et al. Feb 1990 A
4902877 Grasso et al. Feb 1990 A
4941353 Fukatsu et al. Jul 1990 A
4950134 Bailey et al. Aug 1990 A
4967932 Wiley et al. Nov 1990 A
4976162 Kamen Dec 1990 A
4979639 Hoover et al. Dec 1990 A
5002471 Perlov Mar 1991 A
5015389 Portillo et al. May 1991 A
5024756 Stemby Jun 1991 A
5058630 Wiley et al. Oct 1991 A
5074359 Schmidt et al. Dec 1991 A
5088515 Kamen Feb 1992 A
5100554 Polaschegg Mar 1992 A
5116021 Foust et al. May 1992 A
5121855 Credle, Jr. Jun 1992 A
5141130 Wiley et al. Aug 1992 A
5141493 Jacobsen et al. Aug 1992 A
5146713 Grafius Sep 1992 A
5178182 Kamen Jan 1993 A
5181631 Credle, Jr. Jan 1993 A
5192000 Wandrick et al. Mar 1993 A
5193990 Kamen et al. Mar 1993 A
5211201 Kamen et al. May 1993 A
5241985 Faust et al. Sep 1993 A
5252213 Ahmad et al. Oct 1993 A
5300301 Lakin et al. Apr 1994 A
5311899 Isayama et al. May 1994 A
5324422 Collemn et al. Jun 1994 A
5344392 Senninger et al. Sep 1994 A
5350082 Kiriakides et al. Sep 1994 A
5350357 Kamen et al. Sep 1994 A
D351470 Scherer et al. Oct 1994 S
5353837 Faust Oct 1994 A
5395351 Munsch Mar 1995 A
5421208 Packard et al. Jun 1995 A
5421823 Kamen et al. Jun 1995 A
5431626 Bryant et al. Jul 1995 A
5437842 Jensen et al. Aug 1995 A
5438510 Bryant et al. Aug 1995 A
5447286 Kamen et al. Sep 1995 A
5474683 Bryant et al. Dec 1995 A
5486286 Peterson et al. Jan 1996 A
5490447 Giulaino Feb 1996 A
5499741 Scott et al. Mar 1996 A
5540265 Polaschegg et al. Jul 1996 A
5570716 Kamen et al. Nov 1996 A
5572992 Kankkunen et al. Nov 1996 A
5583948 Shibayama Dec 1996 A
5616248 Schal Apr 1997 A
5628908 Kamen et al. May 1997 A
5634896 Bryant et al. Jun 1997 A
5640995 Packard et al. Jun 1997 A
5641405 Keshaviah et al. Jun 1997 A
5641892 Larkins et al. Jun 1997 A
5642761 Holbrook Jul 1997 A
5713865 Manning et al. Feb 1998 A
5728949 McMillan et al. Mar 1998 A
5741125 Neftel et al. Apr 1998 A
5755683 Houle et al. May 1998 A
5757667 Shannon et al. May 1998 A
5771914 Ling et al. Jun 1998 A
5772637 Heinzmann et al. Jun 1998 A
5788099 Treu et al. Aug 1998 A
5797519 Schroeder et al. Aug 1998 A
5803320 Cutting et al. Sep 1998 A
5811581 Piva Sep 1998 A
5884813 Bordonaro et al. Mar 1999 A
5887621 Doll Mar 1999 A
5925011 Faict et al. Jul 1999 A
5925014 Teeple, Jr. Jul 1999 A
5938634 Packard Aug 1999 A
5939644 Hsu Aug 1999 A
5960997 Forsythe Oct 1999 A
5967367 Orsbom Oct 1999 A
5989423 Kamen et al. Nov 1999 A
5992685 Credle, Jr. Nov 1999 A
5997502 Reilly et al. Dec 1999 A
6026847 Reinicke et al. Feb 2000 A
6036680 Home et al. Mar 2000 A
6041801 Gray et al. Mar 2000 A
6042784 Wamsiedler et al. Mar 2000 A
6065941 Gray et al. May 2000 A
6067946 Bunker et al. May 2000 A
6070761 Bloom et al. Jun 2000 A
6118207 Ormemd et al. Sep 2000 A
6126831 Goldau et al. Oct 2000 A
6164621 Bouchard et al. Dec 2000 A
6165154 Gray et al. Dec 2000 A
6187199 Goldau Feb 2001 B1
6210361 Kamen et al. Apr 2001 B1
6220295 Bouchard et al. Apr 2001 B1
6223130 Gray et al. Apr 2001 B1
6234997 Kamen et al. May 2001 B1
6251437 Fischbach Jun 2001 B1
6274106 Held Aug 2001 B1
6312589 Jarocki et al. Nov 2001 B1
6316864 Ormerod Nov 2001 B1
6321587 Demers et al. Nov 2001 B1
6343614 Gray et al. Feb 2002 B1
6364159 Newman et al. Apr 2002 B1
6364857 Gray et al. Apr 2002 B1
6382923 Gray May 2002 B1
6406276 Normand et al. Jun 2002 B1
6416293 Bouchard et al. Jul 2002 B1
6451211 Plester et al. Sep 2002 B1
6459175 Potega Oct 2002 B1
6464667 Kamen et al. Oct 2002 B1
6468424 Donig et al. Oct 2002 B1
6497676 Childers et al. Dec 2002 B1
6503062 Gray et al. Jan 2003 B1
6520747 Gray et al. Feb 2003 B2
6550642 Newman et al. Apr 2003 B2
6558343 Neftel May 2003 B1
6564971 Heyes May 2003 B2
6592542 Childers et al. Jul 2003 B2
6595944 Balschat et al. Jul 2003 B2
6600882 Applegate et al. Jul 2003 B1
6604908 Bryant et al. Aug 2003 B1
6613280 Myrick et al. Sep 2003 B2
6614008 Tidrick Sep 2003 B2
6625824 Lutz et al. Sep 2003 B1
6640650 Matsuzawa et al. Nov 2003 B2
6648240 Simmons Nov 2003 B2
6648845 Gotch et al. Nov 2003 B1
6663359 Gray Dec 2003 B2
6669051 Phallen et al. Dec 2003 B1
6669053 Garson et al. Dec 2003 B1
6685831 Donig et al. Feb 2004 B2
6702774 Polaschegg Mar 2004 B1
6709417 Houle et al. Mar 2004 B1
6726656 Kamen et al. Apr 2004 B2
6729226 Mangiapane May 2004 B2
6745592 Edrington et al. Jun 2004 B1
6746514 Bedingfield et al. Jun 2004 B2
6749403 Bryant et al. Jun 2004 B2
6756069 Scoville et al. Jun 2004 B2
6764761 Eu et al. Jul 2004 B2
6792847 Tobin et al. Sep 2004 B2
6807460 Black et al. Oct 2004 B2
6808369 Gray et al. Oct 2004 B2
6814547 Childers et al. Nov 2004 B2
6845886 Henry et al. Jan 2005 B2
6860866 Graf et al. Mar 2005 B1
6869538 Yu et al. Mar 2005 B2
6911007 Nier et al. Jun 2005 B2
6925011 Pekny et al. Aug 2005 B2
7084769 Bauer et al. Aug 2006 B2
7108790 Collins et al. Sep 2006 B2
7214210 Kamen May 2007 B2
7223426 Cheng et al. May 2007 B2
7232059 Peebles Jun 2007 B2
D556909 Reihanifam et al. Dec 2007 S
D556910 Reihanifam et al. Dec 2007 S
D576281 Reihanifam et al. Sep 2008 S
7617850 Domey Nov 2009 B1
7740152 Hughes et al. May 2010 B2
7878370 Sevcik et al. Feb 2011 B2
8087303 Beavis Jan 2012 B2
8330579 Kneip et al. Dec 2012 B2
8516902 Beavis et al. Aug 2013 B2
8775196 Simpson et al. Jul 2014 B2
8870811 Gavin et al. Oct 2014 B2
9517296 Fulkerson et al. Dec 2016 B2
9542578 Dattolo et al. Jan 2017 B2
9614285 Blumberg, Jr. Apr 2017 B2
9675743 Raiford et al. Jun 2017 B2
9742065 Blumberg, Jr. Aug 2017 B2
9800663 Arrizza Oct 2017 B2
9806399 Blumberg, Jr. Oct 2017 B2
10129338 Arrizza Nov 2018 B2
10305992 Arrizza May 2019 B2
10491678 Arrizza Nov 2019 B2
10532139 Medina et al. Jan 2020 B2
20020000793 Hanaki Jan 2002 A1
20020008032 Hayenga Jan 2002 A1
20020029804 Liorati et al. Mar 2002 A1
20020060226 Kameyama May 2002 A1
20020107474 Noack Aug 2002 A1
20020147423 Burbank et al. Oct 2002 A1
20030018395 Cmkovich et al. Jan 2003 A1
20030029451 Blair et al. Feb 2003 A1
20030085621 Potega May 2003 A1
20030111457 Tidrick Jun 2003 A1
20030130606 Tuck Jul 2003 A1
20030136189 Luuman et al. Jul 2003 A1
20030200812 Kuhn et al. Oct 2003 A1
20030204162 Childers et al. Oct 2003 A1
20030217957 Bowman et al. Nov 2003 A1
20030217961 Hopping Nov 2003 A1
20030217975 Yu et al. Nov 2003 A1
20030218623 Krensky et al. Nov 2003 A1
20030220599 Lundtveit et al. Nov 2003 A1
20030220605 Bowman et al. Nov 2003 A1
20030220607 Busby et al. Nov 2003 A1
20030220608 Huitt et al. Nov 2003 A1
20030220609 Childers et al. Nov 2003 A1
20030220627 Distler et al. Nov 2003 A1
20040010223 Busby et al. Jan 2004 A1
20040019313 Childers et al. Jan 2004 A1
20040019320 Childers et al. Jan 2004 A1
20040031756 Suzuki et al. Feb 2004 A1
20040064080 Cruz et al. Apr 2004 A1
20040067161 Axelsson Apr 2004 A1
20040082903 Micheli Apr 2004 A1
20040122353 Shahmirian et al. Jun 2004 A1
20040135078 Mandro et al. Jul 2004 A1
20040195190 Min et al. Oct 2004 A1
20040261624 Lassota Dec 2004 A1
20050103799 Litterst et al. May 2005 A1
20050113734 Brugger et al. May 2005 A1
20050151422 Gilmour Jul 2005 A1
20050201200 Fleig Sep 2005 A1
20050230292 Beden et al. Oct 2005 A1
20050234381 Niemetzer et al. Oct 2005 A1
20050242034 Connell et al. Nov 2005 A1
20060027267 Fritze Feb 2006 A1
20060044192 Egbert Mar 2006 A1
20060081653 Boland et al. Apr 2006 A1
20060195064 Plahey et al. Aug 2006 A1
20060241550 Kamen Oct 2006 A1
20070085049 Houle Apr 2007 A1
20070152829 Lindsay et al. Jul 2007 A1
20080008609 Pate et al. Jan 2008 A1
20080054837 Beavis et al. Mar 2008 A1
20080073610 Manning Mar 2008 A1
20080204347 Alvey et al. Aug 2008 A1
20090159612 Beavis Jun 2009 A1
20120138533 Curtis et al. Jun 2012 A1
20120203573 Mayer et al. Aug 2012 A1
20140276376 Rohde et al. Sep 2014 A1
20150168188 Reichart Jun 2015 A1
20160109398 Fulkerson et al. Apr 2016 A1
20160239637 Miller et al. Aug 2016 A1
20170043089 Handler Feb 2017 A1
20170050834 Beavis et al. Feb 2017 A1
20170116508 Dattolo et al. Apr 2017 A1
20170125879 Blumberg, Jr. May 2017 A1
20170176558 Jones et al. Jun 2017 A1
20170207536 Blumberg, Jr. Jul 2017 A1
20170239412 Court Aug 2017 A1
20170281846 Manda et al. Oct 2017 A1
20170373394 Blumberg, Jr. Dec 2017 A1
20180043080 Gerber et al. Feb 2018 A1
20180053986 Blumberg, Jr. Feb 2018 A1
20180326138 Kalaskar et al. Nov 2018 A1
20200068021 Arrizza Feb 2020 A1
20200114054 Medina et al. Apr 2020 A1
20200121840 Crnkovich Apr 2020 A1
Foreign Referenced Citations (32)
Number Date Country
10204003 Aug 2003 DE
0034916 Sep 1981 EP
0311848 Apr 1989 EP
0399918 Nov 1990 EP
0532062 Nov 1995 EP
0875431 Nov 1998 EP
0796218 Jul 1999 EP
1050753 Nov 2000 EP
1187642 Mar 2002 EP
1277485 Nov 2006 EP
1783568 May 2007 EP
2569560 Mar 1986 FR
2769954 Apr 1999 FR
2091126 Jul 1982 GB
2004-93065 Mar 2004 JP
WO 9211046 Jul 1992 WO
WO 9218048 Oct 1992 WO
WO 9511855 May 1995 WO
WO 9625214 Aug 1996 WO
WO 9700400 Jan 1997 WO
WO 9937342 Jul 1999 WO
WO 0057935 Oct 2000 WO
WO 0183360 Nov 2001 WO
WO 2002049968 Jun 2002 WO
WO 02059035 Aug 2002 WO
WO 2004089441 Oct 2004 WO
WO 2006036353 Apr 2006 WO
WO 2008143289 Nov 2008 WO
WO 2009090354 Jul 2009 WO
WO 2011066299 Jun 2011 WO
WO 2012041790 Apr 2012 WO
WO 2016049542 Mar 2016 WO
Non-Patent Literature Citations (13)
Entry
U.S. Appl. No. 16/933,664, Arrizza, filed Jul. 20, 2020.
Communication from European Patent Office from European Application No. 13/80435.7, dated Feb. 1, 2016, 8 pages.
DePaula et al., “Clinical consequences of an individualized dialysate sodium prescription in hemodialysis patients,” Kidney International, 2004, 66:1232-1238.
European Search Report dated Mar. 15, 2013, received in European Patent Application No. 08829307.1, 4 pages.
Gambro®, “DEHP-free cartridge blood sets,” ©Nov. 2004, Gambro Inc., Lakewood, CO, 4 Pages.
Gambro®, “Prismaflex™ anticipating critical care needs and taking our innovative response to new heights,” ©2004, Gambro Inc., Lakewood, CO, 8 pages.
Gotch et al., “Mechanisms determining the ration of conductivity clearance to urea clearance,” Kidney International, 2004, 66(89) :S1-S22, 24 pages.
Liljencranis, “Thermal Anemometers”, Amateur Design Report, Jul. 17, 2004, URL <http://fonema.se/anemom/anemom.html>.
Sleep Safe™ Operating Instructions, Fresenius Medical Care, Aug. 2000, 134 pages.
U.S. Appl. No. 29/224,370, filed Feb. 28, 2005, and entitled “Peritoneal Dialysis Cycler”.
U.S. Appl. No. 29/224,371, filed Feb. 28, 2005, and entitled “Cassette for Peritoneal Dialysis Cycler”.
U.S. Appl. No. 29/224,375, filed Feb. 28, 2005, and entitled “Peritoneal Dialysis Cycler”.
Zhou et al., “Impact of sodium and ultrafiltration profiling on haemodialysis-related hypotension,” NDT Advance Access published online on Sep. 5, 2006.
Related Publications (1)
Number Date Country
20200121840 A1 Apr 2020 US
Provisional Applications (1)
Number Date Country
62746720 Oct 2018 US